Pfizer Inc header image

Pfizer Inc

PFE

Equity

ISIN null / Valor 962004

New York Stock Exchange, Inc (2026-10-27)
USD 29.79-0.80%

Pfizer Inc
UMushroom community rating:

star star star star star
4.00 15 votes No rating yet
NegativeNeutralPositive

About company

Pfizer Inc. is a global pharmaceutical corporation that engages in the discovery, development, manufacture, and marketing of a wide range of healthcare products. Its operations span across various segments including innovative health and established health products, focusing on areas such as internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases. Pfizer is known for its commitment to research and development, aiming to address unmet medical needs and improve patient outcomes. The company has made significant strides in the pharmaceutical industry by launching initiatives like an online site for up-to-date information on its U.S. post-marketing commitments, which underscores its dedication to transparency and safety in medicine. Additionally, Pfizer has expanded its reach into animal health through its Agricultural Division, and has ventured into regenerative medicine with the establishment of its Global Regenerative Medicine Unit. The acquisition of Mack Illertissen and the strategic integration of Hospira's portfolio of biosimilars highlight Pfizer's efforts to broaden its product offerings and strengthen its position in the global market. By segmenting its commercial operations into innovative and value business lines, Pfizer aims to cater to both developed and emerging markets, leveraging its scientific expertise and global scale to meet diverse healthcare needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

20.3%1Y
-4.40%3Y
-31.6%5Y

Performance

21.1%1Y
24.5%3Y
25.5%5Y

Volatility

Market cap

169793 M

Market cap (USD)

Daily traded volume (Shares)

25,656,349

Daily traded volume (Shares)

1 day high/low

26.58 / 26.24

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

15 votes
Performance:
starstarstarstarstar
3.21
Innovation:
starstarstarstarstar
3.51
Society:
starstarstarstarstar
4.03
Nature:
starstarstarstarstar
3.26
Parth Goel
UK, 25 Oct 2026
star star star star star
Cheap for a reason: ~10x forward earnings vs Lilly near 30x, but FY26 EPS is seen down 8% and flat in FY27 as Eliquis and Prevnar lose protection, Ibrance and Xtandi in 2027. Metsera obesity asset showed 15.9% weight loss vs tirzepatide ~22%. Q3 on 3 Nov. Mean target $29.45 sits below the price.
Grayton Tan
UK, 25 Oct 2026
star star star star star
very goood
Daniel Brants
Ireland, 19 Oct 2026
star star star star star
medicine i guess

EQUITIES OF THE SAME SECTOR

Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%USD 58.23
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.88%USD 205.70
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.81%USD 20.39
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 90.34
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 41.79
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%INR 790.10
Herbalife Ltd
Herbalife Ltd Herbalife Ltd Valor: 2002103
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%USD 13.28
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.23%USD 9.22
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 31.34
MedNation AG
MedNation AG MedNation AG Valor: 331107
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%EUR 3.96